- Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia News-Medical.Net
- Biotron share price rockets 38% on COVID trial results The Motley Fool Australia
- COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants | Scientific Reports Nature.com
- Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection News-Medical.Net
- Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial The Lancet
- View Full coverage on Google News
Epidemiologic and genomic investigation of SARS-CoV-2 infections associated with two repatriation flights from India to Australia – News-Medical.Net
ByGoogle News
Apr 29, 2022